Related Experiment Video
Updated: May 4, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Epigenetic alteration and microRNA dysregulation in cancer
Hiromu Suzuki1, Reo Maruyama1, Eiichiro Yamamoto1
1Department of Molecular Biology, Sapporo Medical University Sapporo, Japan.
Abstract:
MicroRNAs (miRNAs) play pivotal roles in numerous biological processes, and their dysregulation is a common feature of human cancer. Thanks to recent advances in the analysis of the cancer epigenome, we now know that epigenetic alterations, including aberrant DNA methylation and histone modifications, are major causes of miRNA dysregulation in cancer. Moreover, the list of miRNA genes silenced in association with CpG island hypermethylation is rapidly growing, and various oncogenic miRNAs are now known to be upregulated via DNA hypomethylation. Histone modifications also play important roles in the dysregulation of miRNAs, and histone deacetylation and gain of repressive histone marks are strongly associated with miRNA gene silencing. Conversely, miRNA dysregulation is causally related to epigenetic alterations in cancer. Thus aberrant methylation of miRNA genes is a potentially useful biomarker for detecting cancer and predicting its outcome. Given that many of the silenced miRNAs appear to act as tumor suppressors through the targeting of oncogenes, re-expression of the miRNAs could be an effective approach to cancer therapy, and unraveling the relationship between epigenetic alteration and miRNA dysregulation may lead to the discovery of new therapeutic targets.
Insights
Epigenetic changes like DNA methylation and histone modifications disrupt microRNAs (miRNAs) in cancer. Understanding these epigenetic alterations in miRNA genes offers potential cancer biomarkers and therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- MicroRNAs (miRNAs) are crucial regulators of biological processes.
- Dysregulation of miRNAs is a hallmark of human cancers.
- Epigenetic alterations are increasingly recognized as key drivers of miRNA dysregulation in cancer.
Purpose of the Study:
- To explore the intricate relationship between epigenetic modifications and miRNA dysregulation in cancer.
- To highlight the potential of epigenetic alterations in miRNA genes as cancer biomarkers.
- To investigate miRNA re-expression as a therapeutic strategy for cancer.
Main Methods:
- Analysis of the cancer epigenome.
- Investigation of DNA methylation patterns (hypermethylation and hypomethylation) affecting miRNA genes.
- Examination of histone modifications (e.g., deacetylation, repressive marks) associated with miRNA gene silencing.
Main Results:
- Aberrant DNA methylation (CpG island hypermethylation and DNA hypomethylation) significantly impacts miRNA expression in cancer.
- Histone modifications, including deacetylation and repressive marks, are linked to miRNA gene silencing.
- Evidence suggests a causal relationship where miRNA dysregulation is linked to epigenetic alterations in cancer.
Conclusions:
- Epigenetic alterations in miRNA genes are major contributors to cancer development and progression.
- Aberrant miRNA methylation serves as a potential biomarker for cancer detection and outcome prediction.
- Targeting epigenetic modifications to restore miRNA function presents a promising avenue for novel cancer therapies.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

